NetworkNewsBreaks – Pressure BioSciences, Inc. (
Post# of 1354
(Total Views: 128)
Posted On: 11/08/2017 6:54:36 PM
NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Progresses in Global Life Sciences Industry
Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology. PBIO also recently received patents for its Ultra Shear Technology. An article discussing this reads: “Pressure BioSciences, which completed 2016 with $2 million in sales with only one salesperson on board, has recently added five more people to the sales staff — and the team is diligently working to continue the company’s progress in the industry. Its newest table-top, high-pressure instrument is a finalist in the 2017 R&D 100 Awards, which are often referred to as the “Oscars of Innovation”. Furthermore, key opinion leaders around the globe are beginning to recognize the Barocycler 2320EXT instrument as a “must have” for laboratory research because of the many advantages the instrument has over its competitors, including a new USB output port where data generated by the instrument can be downloaded, making it a useful tool for FDA-required testing in biopharma quality control, a brand new application.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences, Inc. (OTCQB: PBIO) is engaged in the development and sale of innovative solutions for the worldwide life sciences industry. The company is advancing in the industry, with its patented high pressure cycling technology. PBIO also recently received patents for its Ultra Shear Technology. An article discussing this reads: “Pressure BioSciences, which completed 2016 with $2 million in sales with only one salesperson on board, has recently added five more people to the sales staff — and the team is diligently working to continue the company’s progress in the industry. Its newest table-top, high-pressure instrument is a finalist in the 2017 R&D 100 Awards, which are often referred to as the “Oscars of Innovation”. Furthermore, key opinion leaders around the globe are beginning to recognize the Barocycler 2320EXT instrument as a “must have” for laboratory research because of the many advantages the instrument has over its competitors, including a new USB output port where data generated by the instrument can be downloaded, making it a useful tool for FDA-required testing in biopharma quality control, a brand new application.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼